Janssen Pharmaceuticals must pay $124.3 million of $327 million awarded by a Spartanburg jury in a case involving the antipsychotic drug Risperdal.
Janssen Pharmaceuticals must pay $124.3 million of $327 million awarded by a Spartanburg jury in a case involving the antipsychotic drug Risperdal.
Janssen Pharmaceuticals must pay $124.3 million of $327 million awarded by a Spartanburg jury in a case involving the antipsychotic drug Risperdal.

Pharmaceutical company owes SC $124 million for losing drug case, US Supreme Court says

January 21, 2016 8:55 PM